Evidence map›Paper›PMID 33296695›Full record

ArticleAntiviral research2021

The NF-κB inhibitor, SC75741, is a novel antiviral against emerging tick-borne bandaviruses.

Crystal A Mendoza, Satoko Yamaoka, Yoshimi Tsuda, Keita Matsuno, Carla M Weisend, Hideki Ebihara

Open access · greenAbstract read
In one paragraph

Article in Antiviral research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. An orally available 4Journal of virology · 2025
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Crystal A MendozaMayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, 55905, USA.
Satoko YamaokaMayo Clinic, Department of Molecular Medicine, Rochester, MN, 55905, USA.
Yoshimi TsudaDepartment of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, 060-8638, Japan.
Keita MatsunoUnit of Risk Analysis and Management, Hokkaido University Research Center for Zoonosis Control, Sapporo, Hokkaido, 001-0020, Japan; International Collaboration Unit, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, 001-0020, Japan.
Carla M WeisendMayo Clinic, Department of Molecular Medicine, Rochester, MN, 55905, USA.
Hideki EbiharaMayo Clinic, Department of Molecular Medicine, Rochester, MN, 55905, USA. Electronic address: Ebihara.Hideki@mayo.edu.
Mayo Clinic in Arizona · USHokkaido University · JP

Funding

PhD Training Program in Virology and Gene TherapyT32AI132165 · NIAID · MAYO CLINIC ROCHESTER · PI ROBERTO B. CATTANEO · 2018 to 2026
$1.3M
NIAID NIH HHS T32 AI132165
6 · The paper itself

Abstract

Severe fever with thrombocytopenia syndrome virus (SFTSV) and Heartland virus (HRTV) cause viral hemorrhagic fever-like illnesses in humans due to an aberrant host inflammatory response, which contributes to pathogenesis. Here, we established two separate minigenome (MG) systems based on the M-segment of SFTSV and HRTV. Following characterization of both systems for SFTSV and HRTV, we used them as a platform to screen potential compounds that inhibit viral RNA synthesis. We demonstrated that the NF-κB inhibitor, SC75741, reduces viral RNA synthesis of SFTSV and HRTV using our MG platform and validated these results using infectious SFTSV and HRTV. These results may lead to the use of MG systems as potential screening systems for the identification of antiviral compounds and yield novel insights into host-factors that could play role in bandavirus transcription and replication.

Indexed as

AnimalsAntiviral AgentsChlorocebus aethiopsDrug DiscoveryGenome, ViralHEK293 CellsHost-Pathogen InteractionsHumansInhibitory Concentration 50NF-kappa BPhlebovirusTHP-1 CellsTicksVero CellsAntiviral AgentsNF-kappa BAnd minigenomeAntiviralBandavirusHeartland virusSevere fever with thrombocytopenia syndrome virus

Identifiers

PMID33296695
PMCPMC8077392
OpenAlexW3111480274

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.